Based on a literature search, follow-up studies on auranofin and its effects on TRPA1 in in vivo systems have not yet been performed, and no additional manuscripts examining TRPA1 agonists for the treatment of arthritis could be identified. Here, TRPA1 is linked to arthritic joint disease.